⌘K
Loading ticker…
As of 2026-08-24, Tyra Biosciences, Inc. Common Stock (TYRA) has a 3-month relative strength percentile of 20 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 57. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.7%, relative volume 0.50×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
TYRA is in a stage 3 topping pattern, week 7. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -12.0% / -12.5%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
TYRA is held by 22 ETFs as of May 2026. Top owner: VTWO at 0.03% weight, $4M notional. Top 3 carry $11M.
Held by 42 ETFs · $134M across latest filings · largest weight 1.54% (PTH).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.03% | $4M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.02% | $4M | — |
| VFMO | 0.15% | $3M | +0.01 pp |
| SBIO | 1.15% | $2M | — |
| VHTVanguard Health Care ETF | 0.01% | $1M | — |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.31% |
| $1M |
| −0.16 pp |
| VTWV | 0.05% | $678K | — |
| ONEQ | 0.01% | $603K | — |
| CANC | 0.30% | $527K | −0.29 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $438K | — |
Showing 10 of 22 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TYRA Jan avg: 14.44% median: 10.63% win: 75% σ: 18.88% n: 4 2022-04-12 → 2026-07-31 | TYRA Feb avg: 15.66% median: 16.23% win: 75% σ: 28.63% n: 4 2022-04-12 → 2026-07-31 | TYRA Mar avg: -0.48% median: -1.49% win: 50% σ: 21.90% n: 4 2022-04-12 → 2026-07-31 | TYRA Apr avg: -5.60% median: -9.27% win: 40% σ: 13.08% n: 5 2022-04-12 → 2026-07-31 | TYRA May avg: -5.42% median: -5.15% win: 20% σ: 5.20% n: 5 2022-04-12 → 2026-07-31 | TYRA Jun avg: 4.35% median: 4.69% win: 60% σ: 8.49% n: 5 2022-04-12 → 2026-07-31 | TYRA Jul avg: 17.72% median: 14.21% win: 60% σ: 25.91% n: 5 2022-04-12 → 2026-07-31 | TYRA Aug avg: -4.13% median: 2.74% win: 75% σ: 23.37% n: 4 2022-04-12 → 2026-07-31 (current) | TYRA Sep avg: 9.28% median: 6.86% win: 75% σ: 17.84% n: 4 2022-04-12 → 2026-07-31 | TYRA Oct avg: -13.21% median: -18.52% win: 25% σ: 18.45% n: 4 2022-04-12 → 2026-07-31 | TYRA Nov avg: 9.67% median: 1.12% win: 75% σ: 22.09% n: 4 2022-04-12 → 2026-07-31 | TYRA Dec avg: 7.97% median: 12.47% win: 75% σ: 13.58% n: 4 2022-04-12 → 2026-07-31 |